Thus, in this study, we started by assessing sites differentially bound by MYC, AR, and HOXB13 in the setting of high or low MYC expression using LNCaP PCa cells to identify novel transcriptional regulators that likely contributed to changes in MYC activity over the course of human PCa progression. The gene discussed is AR; the disease is posterior cortical atrophy.